13 Jun 2013
The Company announces that on 12 June 2013, Subhransu “Brian” Mukherjee, Chief Executive Officer and Director, and Suranga Chandratillake, Chief Strategy Officer and Director, notified the Company that each had exercised options of blinkx plc Ordinary Shares (‘blinkx Shares’). Subhransu Mukherjee exercised 160,000 options of blinkx Shares at an exercise price of £0.39 per share and 140,000 options of blinkx Shares at an exercise price of £0.49 per share both on 12 June 2013, and subsequently sold those blinkx Shares at an average-weighted price of £1.1342 per share on 12 June 2013. Suranga Chandratillake exercised 1,600,000 options of blinkx Shares at an exercise price of £0.01 per share on 12 June 2013, and subsequently sold those blinkx Shares at an average-weighted price of £1.1440 per share.
These share options were granted under the blinkx US Share Option Plan. Following these transactions, Subhransu Mukherjee still has 2,280,000 share options in the Company and Suranga Chandratillake still has 3,226,057 share options in the Company.
On 12 June 2013 Dr Michael R Lynch, a Non-Executive Director, notified the Company that on 12 June 2013 he sold 1,000,000 blinkx Shares at a price of £1.1332 per share. The transaction represented approximately 4.6% of Dr Lynch’s holding, and following the transaction Dr. Lynch has an interest in 20,902,712 blinkx Shares, representing 5.7% of the Company’s issued share capital.
For further information please contact:
Capita Company Secretarial Services
+44 (0) 207 954 9543
Citigroup Global Markets Ltd
NOMAD and Broker for the Company
+44 (0)207 986 9756